Boron neutron capture therapy: Preliminary study of BNCT with sodium borocaptate (Na2B12H11SH) on glioblastoma

Journal of Neuro-Oncology

Volumn 35, Issue 2, 1997, Pages 177-185

  Takagaki, Masao ^a   Oda, Yoshifumi ^a   Miyatake, Shin Ichi ^a   Kikuchi, Haruhiko ^a   Kobayashi, Toru ^a   Sakurai, Yoshinori ^a   Osawa, Masami ^a,b   Mori, Kenjiro ^a,b   Ono, Koji ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KOBE CITY MEDICAL CENTER GENERAL HOSPITAL   (Japan)

Author keywords

10B quantitative distribution; Boron neutron capture therapy; Malignant brain tumors; Sodium borocaptate

Indexed keywords

BOROCAPTATE; BORON DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; AUTORADIOGRAPHY; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG DISTRIBUTION; DRUG TUMOR LEVEL; GAMMA SPECTROMETRY; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; NEUTRON CAPTURE THERAPY; PARENCHYMA; TISSUE LEVEL;

BOROHYDRIDES; BORON NEUTRON CAPTURE THERAPY; DOSE-RESPONSE RELATIONSHIP, RADIATION; GLIOBLASTOMA; HUMANS; SULFHYDRYL COMPOUNDS;

EID: 0030742363     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005766828165     Document Type: Article

References (23)

1. Oda Y, Takagaki M, Zhen H, Nakatsu S, Miyatake S, Nakao H, Kikuchi H: Early clinical experience of boron neutron capture therapy for glioblastoma patients. In: The Progress of the 5th International Symposium of Neutron Capture Therapy for Cancer 214-217, 1993
2. Hatanaka H: The present status of boron-neutron capture therapy for brain tumors and a limited clinical experience of californium-252-boron-10-therapy. Nucl Sci Appl 4: 335-348, 1991
3. 10B-neutron capture therapy: Enhancement of tumor dose via beam filtration and dose rate, and the effects of these parameters on minimum boron content: A theoretical evaluation. Int J Radiat Oncol Biol Phys 11: 831-840, 1985
4. Ono K, Masunaga S, Kinashi Y, Takagaki M, Kobayashi T, Imahori Y, Ueda S, Oda Y: The dose planning of BNCT for brain tumors. In: The Progress of the 6th International Symposium on Neutron Capture Therapy for Cancer, 1996, in press
5. Kobayashi T, Kanda K: Microanalysis system of ppm-order B-10 concentration in tissue for neutron capture therapy by prompt gamma-ray spectrometry. Nucl Instr Meth 204: 525-531, 1983
6. Fleisher RL, Price PB, Walker RM: Nuclear Tracks in Solids, Principles and Applications, Chap. 1 and 2, pp. 3-118, 1975
7. Kanda K, Kobayashi T, Ono K, Sato T, Shibata T, Ujeno Y, Mishima Y, Hatanaka H, Nishiwaki Y: Elimination of gamma rays from a thermal neutron field for medical and biomedical irradiation purpose. IAEA-SM-193/68, Biomedical Dosimetry, pp. 205, IAEA, Vienna, Austria, March 10-14, 1975
8. Katz R, Kobetich EJ: Formation of etchable tracks in dielectrics. Phys Rev 170: 401, 1968
9. Takagaki M, Mishima Y: Boron-10 quantitative analysis of neutron capture therapy on malignant melanoma by spectrophotometric α-track reading. Nucl Tracks Radiat Meas 17 (4): 531-535, 1990
10. Gabel D, Holstein H, Larsson B, Gille L, Ericson G, Sacker D, Som P, Fairchild RG: Quantitative neutron capture radiography for studying the biodistribution of tumor-seeking boron-containing compounds. Cancer Res 47: 5451-5454, 1987
11. 1 1SH (BSH) in patients with malignant glioma as precondition for boron neutron capture therapy (BNCT). Int J Radiat Oncol Biol Phys 28: 1175-1181, 1984
12. Kraft SL, Gavin PR, Dehaan CE, Leathers CW, Bauer WF, Miller DL, Dorn III RV: Borocaptate sodium: A potential boron delivery compound for boron neutron capture therapy evaluated in dogs with spontaneous intracranial tumors. Proc Natl Acad Sci USA 89: 11973-11977, 1992
13. 1 1SH in patients with glioblastoma. Cancer Res 54: 6318-6320, 1994
14. 1 1SH, European Collaboration on Boron Neutron Capture Therapy, Version of 27 October, 1995
15. 10B concentration in quantitative neutron capture radiography. 6th International Symposium on Neutron Capture Therapy for Cancer, Abstract pp. 96, Oct. 31-Nov. 4, Kobe, Japan, 1994
16. Rizzoli HV, Pagnanelli DM: Treatment of delayed radiation necrosis of the brain, a clinical observation. J Neurosurg 60: 589-594, 1984
17. Kobayashi T, Kanda K: Analytical calculation of boron-10 dosage in cell nucleus for neutron capture therapy. Radiat Res 91: 77-94, 1982
18. Bradshaw KM, Schweizer MP, Hadley JR, Tippets RH, Tang P-PZ, Glover GH, Heilbrum MP, Johnson S, Hendee SP: Boron MRI in a tumor bearing canine model. 6th International Symposium on Neutron Capture Therapy for Cancer, Abstract pp. 46, Oct. 31-Nov. 4, Kobe, Japan, 1994
19. Giese A, Westphal M: Glioma invasion in the central nervous system (Topic review). Neurosurg 39 (2): 235-252, 1996
20. Kitao K: Vascular wall dose from boron neutron capture reaction. In: Hatanaka H (ed) Boron-Neutron Capture Therapy for Tumors. Nishimura Co., Ltd., 191-202, 1986
21. Rydin RA, Deutsch OL, Murray BW: The effect of geometry on capillary wall dose for boron neutron capture therapy. Phys Med Biol 21: 134-138, 1976
22. Takagaki M, Oda Y, Koda Y, Kikuchi H, Ono K: Effectiveness of borocaptate sodium for boron neutron capture therapy in malignant brain tumors. In: The Progress of the 6th International Symposium on Neutron Capture Therapy for Cancer, 1996, in press
23. Takagaki M, Oda Y, Kikuchi H, Ono K, Masunaga S: Is BSH effective or not on BNCT for malignant brain tumors? Kyoto University Research Reactor Institute - Technical Report 382: 14-28, 1993